DAVENPORT & Co LLC lessened its position in GSK plc (NYSE:GSK – Free Report) by 1.1% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 31,522 shares of the pharmaceutical company’s stock after selling 343 shares during the period. DAVENPORT & Co LLC’s holdings in […]
RKL Wealth Management LLC purchased a new position in shares of GSK plc (NYSE:GSK – Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 7,107 shares of the pharmaceutical company’s stock, valued at approximately $263,000. Several other hedge funds have also recently added […]
Douglas Lane & Associates LLC decreased its position in GSK plc (NYSE:GSK – Free Report) by 3.3% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 2,236,164 shares of the pharmaceutical company’s stock after selling 75,727 shares during the period. GSK comprises approximately 1.3% of Douglas Lane & […]
GPS Wealth Strategies Group LLC decreased its stake in shares of GSK plc (NYSE:GSK – Free Report) by 15.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,885 shares of the pharmaceutical company’s stock after selling 525 shares during the period. […]
Cohen Klingenstein LLC lessened its holdings in GSK plc (NYSE:GSK – Free Report) by 6.3% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 123,940 shares of the pharmaceutical company’s stock after selling 8,400 shares during the period. Cohen Klingenstein LLC’s holdings in GSK were […]